NYSE, AZN - Astrazeneca Plc
The information (including tabular data) set forth under the headings
?Additional Information?Corporate Information?History and Development of the
Company? on page 200, ?Directors? Report?Our Resources, Skills and
Capabilities?Supply and Manufacturing?Supply capability? on page 34, ?Directors?
Report?Financial Review?Financial Position, Including Cash Flow and
Liquidity?Property, plant and equipment?, ??Cash flow? and ??Investments,
divestments and capital expenditure? on pages 81 to 83, ?Directors?
Report?Financial Review?Acquisition of MedImmune?, on pages 83 and
84, ?Financial Statements?Notes to the Financial Statements?Note 8?Property,
Plant and Equipment? on pages 131 and 132 and ?Financial Statements?Notes to the
Financial Statements?Note 24?Acquisitions of Business Operations? on pages 145
to 148, in each case of the Company?s ?Annual Report and Form 20-F Information
2007? included as exhibit 15.1 to this Form 20-F dated March 12, 2008 is
incorporated by reference. ...
Read SEC Filing on NASDAQ.com »